News All the latest news and information about the care, research, teaching and management we do at Vall d’Hebron Barcelona Hospital Campus. Don't miss any details! Fulltext search Search Vall d'Hebron identifies that patients with diabetes and myocardial insulin resistance have high cardiovascular risk 24/01/2022 Vall d’Hebron and IDIAP Jordi Gol join forces to research cardiovascular diseases and diabetes 30/11/2021 IMIDomics, a Vall d'Hebron spin-off, raises $16.5 million to develop new drugs against immunomediated inflammatory diseases 27/07/2021 Two VHIR researchers have received awards at the Catalan Health Institute's 2021 Research Awards 27/06/2021 Endolipid Therapeutics, the spin-off of Vall d’Hebron and GENESIS Ventures, emerges to develop a new strategy to reduce visceral and subcutaneous fat 16/06/2021 Pagination « First First page ‹ Previous Previous page 1 2